Subscribe to Newsletter
Manufacture Business Practice, Clinical Trials, Drug Delivery, Formulation, Small Molecules, Trends & Forecasts

The big reveal: Workhorse + Innovation = more information (Part 1)

sponsored by Malvern Panalytical

In other areas the converse is true. Progress is too often hampered by our inability to gather the information needed to make advances. A topical example of this challenge is seen in the pharmaceutical industry where deformulation - the unpicking and rationalization of the performance of a reference labelled drug product - is an essential precursor to the development of a generic equivalent. The FDA has publicly acknowledged the difficulties in replicating complex drugs and has called for advances in analytical instrumentation to help.1

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Related White Papers
Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine